Biosynthetic controls in microorganisms generally maximize the use of exogenously available nutrients over those endogenously synthesized. This spares the organism the metabolic expense of forming those compounds. An anomalous situation appears to exist in the yeast Saccharomyces cerevisiae with regard to the 28-carbon membrane lipid, ergosterol. Under aerobic conditions, wild-type yeast strains synthesize large amounts of ergosterol and do not incorporate significant amounts of exogenous sterol (17) . Under anaerobic conditions, sterol cannot be produced by the organism, and exogenously supplied sterol is utilized by the cells (1) . The physiological advantage of this system is not apparent, because it would seem more efficient to curtail endogenous synthesis of sterol when it is available in the medium than to prevent its transport and require synthesis to occur.
Anaerobic conditions have been used to induce a sterol requirement to study the structural features of sterols needed for growth of this organism (8) . Because of the difficulty of manipulating the anaerobic system, attempts have been made to develop an aerobic alternative for probing structure-function relationships in sterols. Auxotrophs which are unable to synthesize sterols offer a means of restricting sterol synthesis; however, the isolation of mutants which are tightly and unconditionally blocked in sterol synthesis and which are otherwise prototrophic has not been reported previously. An apparent requirement for a concomitant genetic defect in heme synthesis along with sterol auxotrophy has been observed by Gollub et al. (4) and in our laboratory (unpublished data). Attempts to segregate recombinant 2,3-oxidosqualene cyclase mutants from the hem (heme biosynthesis-defective) backgrounds in which they were originally isolated have been unsuccessful. The hem mutations somehow allow for the viability of these sterolauxotrophic strains.
The first sterol auxotroph used in our laboratory, FY1, was derived from one of the first sterol-requiring mutants isolated, Ole3, shown to lack 8-aminolevulinic acid (ALA) synthetase activity (19) ; this locus is now referred to as hemi. The methionine, and sterol in the heme-deficient conditions, but may also be supplemented by ALA alone to meet these requirements. Strain FY1 possesses the hem) allele and grows poorly on cholesterol as its sterol supplement. A rapid-growing variant, FY3, was selected from this genetic background and was found to have acquired an additional mutation in ergosterol biosynthesis at the point of cyclization of 2,3-oxidosqualene (16) .
We present here our studies on the control of sterol uptake by S. cerevisiae and the effects elicited by restoring the potential for heme synthesis by heme mutants. These studies were performed by using nutritional supplementation to manipulate the potential for heme synthesis by FY3 and other heme mutants. In addition, a genetic approach was taken by using a technique which allowed the identification of strains that accumulate increased amounts of exogenous sterol.
MATERIALS AND METHODS
Yeast strains. The yeast strains used in this study are listed in Table 1 .
Media and growth conditions. The standard growth medium used was adjusted to pH 5.5 and consisted of 0.67% yeast nitrogen base (Difco Laboratories), 0.05 M succinic acid, 2% glucose, and the following at 0.02%: methionine, uracil, histidine, tyrosine, tryptophan, phenylalanine, leucine, lysine, and adenine sulfate. Sterol was added at a concentration of 20 ,ug/ml from a stock solution of 4 mg/ml in Tergitol Nonidet P-40-95% ethanol (1:1, vol/vol). Unsaturated fatty acid supplementation was with either 1% Tween 80 or a mixture of oleic and palmitoleic acids (4:1, vol/vol) at 0.01% final concentration added from a 10% solution in Tergitol-ethanol. ALA was supplemented to a final concentration of 0.005% (300 ,uM) from a 1% stock solution in 95% ethanol. Protoporphyrin IX (PPIX) and hematin were added to a final concentration of 10 ,ug/ml from 1% (wt/vol) solutions in 0.01 N KOH in 50% ethanol.
For depletion of sterol, cells of strain FY3 were grown to maximal cell density in medium containing cholestanol (5ot- per ml. The original master plate was stored under refrigeration. After three days of incubation at 30°C, the filters were removed from plates and alternately blotted three times on filter paper saturated with 0.5% Tergitol Nonidet P-40 solution and then on dry filter paper, to remove nonincorporated radioactivity. After the filter was wetted again, the colonies were transferred to paper filters (9.0 cm, Whatman no. 1) by pressing the nitrocellulose and paper disks together. These were then placed in a 60°C oven until the colonies dried thoroughly. The brittle nitrocellulose filter was removed, leaving the dried colonies adhered to the paper. The filter disks were then autoradiographed by exposing them to Kodak XAR-5 X-ray film for 3 days at room temperature before they were developed. Colonies showing the greatest radioactivity were then picked from the original plate and screened for sterol uptake as described above, as well as for growth on minimal medium and a nonfermentable energy source (glycerol).
Determination of sterol intermediates accumulated. Strains were inoculated into standard medium containing 0.2 ,uCi of [1-14C] acetate (specific activity, 55 mCi/mmol) per ml and 0.5% glucose plus the respective nutritional requirements and were grown to stationary phase. Nonsaponifiable lipids were extracted and applied to silica gel thin-layer plates adjacent to pure standards of cholesterol, lanosterol, farnesol, and squalene. These samples were chromatographed by using the solvent system cyclohexane-ethyl acetate (9:1, vol/vol). Bands were visualized by I2 vapor. The distribution of radioactivity on plates was determined with a Packard model 7201 scanner.
Chemicals. Sterols, amino acids, hematin, ALA, and nucleotide bases were from Sigma Chemical Co. PPIX was from Calbiochem-Behring. Solvents were from Mallinckrodt, Inc., and were redistilled before use. Highly purified cholestanol was the gift of Henry Kircher. [4- 14C]cholesterol (specific activity, 59.4 mCi/mmol) was from New England Nuclear Corp. [1-14C] acetate (specific activity, 55 mCi/mmol) was from ICN Pharmaceuticals, Inc. Silica gel plates (F254, 0.25-mm thickness) were from E. Merck AG.
RESULTS
Growth response of hem) and hem) erg7 strains to ALA. The effect of ALA on the growth of strains FY1 (hem)) and FY3 (hem) erg7) is shown in Fig. 1 (Fig. 3 ). This figure also shows that the control culture completed the expected cycle of steryl ester hydrolysis and sterol esterification seen in wild-type cultures (15) but that the ALA-grown culture did not replenish the ester pool (Fig.  3C) . It can also be seen that endogenous stores of sterol (steryl esters) become maximally depleted at the time growth inhibition becomes apparent.
The effect of ALA on sterol uptake was also measured when ALA was added to exponential-phase cells (Fig. 4) . The growth of the culture receiving ALA paralleled the growth of the control in this experiment; however, the amount of free sterol per cell in ALA-exposed cells decreased continually from the point of ALA addition until growth stopped, while the amount of free sterol in control cells remained relatively constant. The amount of radioactive sterol appearing in steryl esters increased steadily as the stationary phase was approached by the control culture, but the ALA-supplemented culture again showed no increase in this fraction.
Potential for hemoprotein synthesis and sterol uptake. The metabolic occurrence of ALA is unique to the heme biosynthetic pathway; therefore, it seemed most likely that heme or hemoprotein was responsible for the effects incurred during ALA supplementation. Before discarding the possibility that complete metabolism of ALA to heme was not necessary to manifest the effects of ALA on sterol uptake, we examined the effect of ALA on other heme mutants. Six mutants, each blocked in one of the eight steps of heme biosynthesis (Fig. 5 ), were grown with and without ALA supplementation. The uptake of cholesterol was measured under these circumstances to determine whether ALA itself or another subsequent precursor was responsible for the inhibition of sterol uptake. These mutants should either have their mutant phenotype suppressed (in the hemi strain) or accumulate different porphyrin intermediates upon metabolism of ALA (18) . It should be noted that only one of these strains (G121) required sterol, suggesting that the other mutations are leaky to some extent, but all were negative for catalase and growth on glycerol. The intracellular heme levels were also found to be below limits of detection (18) . The results of examination of sterol uptake by nine heme mutants with various heme supplements are listed in Table 2 . Cholesterol uptake was seen in all of these strains without ALA and in all strains except the hem] strain when ALA was present in the growth medium. ALA also had no effect on the uptake of sterol or growth of strain GL7 (hem3 [urogen I synthase-] erg12 [oxidosqualene cyclase-]), an independently isolated sterol auxotroph. Based on these data it seems unlikely that ALA itself or another intermediate of the heme biosynthetic pathway is causing the inhibition of sterol uptake.
We also observed the effect of the porphyrins, PPIX and hematin, on sterol uptake by the heme mutants and sterol auxotrophs ( Table 2 ). These porphyrins were less effective heme supplements than ALA as they did not restore respiratory competence (ability to grow on glycerol as the energy source) or ergosterol synthesis to FY1 cells. PPIX ergosterol, presumably precursors, by FY1 (data not shown). These porphyrins also did not prevent sterol uptake by heme mutants G204, G207, G210, G121, G214, or G216. The limited effectiveness of porphyrin heme supplements, compared with ALA, was also observed previously by others (3). This evidence indicates that the efficiency with which a supplement affects cytochrome-dependent metabolism (i.e., respiration or ergosterol biosynthesis) is related to its ability to inhibit sterol uptake.
Other evidence for the idea that cytochrome-restoring levels of heme synthesis must occur to prevent sterol uptake and the growth of sterol auxotrophs comes from the isolatiop of a strain, derived from FY3, which was not inhibited by ALA. This strain, PFY3A, was obtained from a culture of FY3 which had reached stationary phase in ALA-containing medium. Strain PFY3A was identified by a greater accumulation of sterol in the presence of ALA, relative to other colonies of the population (data not shown). This resistant strain had acquired the additional characteristic of an inability to grow on media devoid of unsaturated fatty acid but supplemented with a low, subinhibitory concentration of ALA. FY3 grows on this type of medium. Strain PFY3A resembled FY3 in that it did not require unsaturated fatty acid when PPIX was included in the growth medium. Because unsaturated fatty acid was required by FY3 due to the lack of heme synthesis and, therefore, cytochromes, this evidence indicated that an additional defect between the steps of ALA permeation and iron insertion into PPIX had been acquired by strain PFY3A, again correlating the ability to synthesize heme with the negative effect on sterol uptake.
Genetic studies on sterol uptake control. The fact that sterol uptake occurred when sterol was not required (in the presence of a leaky heme mutation or under semianaerobic conditions [7] ) and was inhibited when heme synthesis but not sterol synthesis could occur (FY3 with ALA) indicated that a system of sterol uptake control exists which responds to heme synthesis. On this basis, we assumed that it should be possible to obtain mutants which are uncoupled in this response and which take up sterol concurrent with heme and ergosterol synthesis. By using the autoradiographic technique described above, we screened for the uptake of sterol colonies from a mutagenized culture of wild-type yeast cells which had grown on media containing [14C]cholesterol. Mutants were found which would take tp exogenously supplied cholesterol, whereas the unmutagenized parent strain would not. The strains were then screened for the ability to grow on minimal medium and on media containing glycerol as the sole energy source. Strain TL-Upc27 is one strain obtained in this manner and one whose phenotype was examined in more detail to determine whether other distinguishing traits accompanied its ability to accumulate exogenous sterol.
Defects in sterol biosynthesis can be revealed by chromatographic analysis of nonsaponifiable lipids (9) . Because no requirement for sterol was found in strain TL-Upc27, any defect in sterol biosynthesis would necessarily have been either late in the ergosterol biosyhthetic pathway or leaky and occurring in an early step. Strairi TL-Upc27 accumulated radioactivity from [1-'4C]acetate into nonsaponifiable lipids which migrated with the same Rf as those of the parent, wild-type strain in a TLC system which separated sterol precursors (Fig. 6) . This was an indication that defects in the early portion of the sterol biosynthetic pathway were not present in strain TL-Upc27. Gas chromatographic analysis also revealed no differences in the nonsaponifiable lipids from strain TL-Upc27 and those of the wild-type strain (data not shown), whereas mutants defective in late steps of the ergosterol biosynthetic pathway were readily detected in this manner.
These data indicate that strain TL-Upc27 differed from the wild type in its ability to accumulate exogenous sterol or inability to exclude it. Because our data indicate that heme biosynthesis is involved in this process and because crosses between wild-type and FY3 yielded viable erg7 spores only in a hem) background, we presumed that a defective sterol uptake control mechanism, such as that of strain TL-Upc27, may allow the viability of erg7 spores in a HEM] genetic background. This prediction was tested by screening for HEM) erg7 strains among haploids produced by sporulation of a diploid heterozygous for hem), erg7, and upcl (sterol uptake control) alleles. This diploid was obtained by mating (Fig. 7) . This was expected of a A model of sterol uptake control involving heme is consistent with some of the observations of sterol uptake and sterol auxotrophy in S. cerevisiae. Under anaerobic conditions, in which sterol uptake must occur to permit growth, heme synthesis would be precluded by the oxygen requirements of coproporphyrinogen decarboxylation (10) and protoporphyrinogen oxidation (11) . A heme-dependent system of control over sterol uptake might also be expected to limit the number of possible genetic backgrounds from which sterol auxotrophs can be isolated. As was mentioned above, tight, unconditional sterol-auxotrophic mutants have previously been isolated only in hem backgrounds. There is good evidence, however, that enzymes of the early steps of ergosterol biosynthesis (i.e., before squalene synthesis) are vital to the cell for supplying metabolic intermediates used in systems other than sterol synthesis, thereby making a complete loss of these functions lethal to the cell (13 
